News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Francesco Massari: Global real-world experience in mUC treatment
Photo taken from Francesco Massari/X
Oct 11, 2024, 13:58

Francesco Massari: Global real-world experience in mUC treatment

Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, posted the following on X:

“Is it feasible EV following platinum chemotherapy and avelumab maintenance in patients with mUC? Out now our real-world global experience by ARON Group.”

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study

Authors: Ondřej Fiala, Francesco Massari, Umberto Basso, Patrizia Giannatempo, Enrique Grande, Sebastiano Buti, Zin W. Myint, Ugo De Giorgi, Renate Pichler, Francesco Grillone, Yüksel Ürün, Fabio Calabrò, Maria T. Bourlon, Luca Galli, Ravindran Kanesvaran, Giandomenico Roviello, Jakub Kucharz, Mimma Rizzo, Se Hoon Park, Linda Cerbone, Emmanuel Seront, Carlo Messina, Javier Molina-Cerrillo, Daniele Santini, Akihiro Yano, Lorena Incorvaia, Martina Catalano, Alvaro Pinto, Luigi Formisano, Andrey Soares, Gaetano Facchini, Giuseppe Fornarini, Alexandr Poprach, Sara Elena Rebuzzi, Cecilia Nasso, Gian Paolo Spinelli, Martin Angel, Marco Stellato, Deniz Tural, Gaetano Aurilio, Ilana Epstein, Francesco Carrozza, Fernando Sabino Marques Monteiro, Giovanni Benedetti, Tomáš Büchler, Cinzia Ortega, Roubini Zakopoulou, Nicola Battelli, Camillo Porta, Joaquin Bellmunt, Shilpa Gupta & Matteo Santoni.

Francesco Massari: Global real-world experience in mUC treatment

Source: Francesco Massari/X

Akihiro Yano Alexandr Poprach Alvaro Pinto Andrey Soares avelumab maintenance Camillo Porta cancer Carlo Messina Cecilia Nasso chemotherapy Cinzia Ortega Daniele Santini Deniz Tural Emmanuel Seront Enrique Grande Fabio Calabrò Fernando Sabino Marques Monteiro Francesco Carrozza Francesco Grillone Francesco Massari Gaetano Aurilio Gaetano Facchini Gian Paolo Spinelli Giandomenico Roviello Giovanni Benedetti Giuseppe Fornarini Ilana Epstein Jakub Kucharz Javier Molina Cerrillo Joaquin Bellmunt Linda Cerbone Lorena Incorvaia Luca Galli Luigi Formisano Marco Stellato Maria T Bourlon Martin Angel Martina Catalano Mimma Rizzo mUC Nicola Battelli OncoDaily Oncology Ondřej Fiala Patrizia Giannatempo Ravindran Kanesvaran Renate Pichler Research Roubini Zakopoulou Sara Elena Rebuzzi Se Hoon Park Sebastiano Buti Shilpa Gupta & Matteo Santoni Tomas Buchler Ugo de Giorgi Umberto Basso Yüksel Ürün Zin W. Myint
Special Coverage
Blog
Dec 21, 2024, 08:18
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers?
Career
Dec 21, 2024, 08:12
Rishabh Singh: Honored to receive the Mary Draeger Schultz Scholarship 2024
Science
Dec 21, 2024, 07:56
Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer
Career
Dec 21, 2024, 07:45
OncoInfluencers to Follow on Social Media: Dr. Liang Cheng
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer
Science
Dec 21, 2024, 07:05
Naseema Gangat: Practical prognostic tool for the current standard of care in older/unfit AML
Blog
Dec 21, 2024, 05:54
LCC in Spanish: LALCA 2024 Highlights
Blog
Dec 21, 2024, 05:50
The Opportunities Are Endless: CU Cancer Center leader Enrique Soto Pérez de Celis signs key international agreement
Insight
Dec 21, 2024, 05:42
Raffaella Casolino: How to integrate cancer into crisis?
Insight
Dec 21, 2024, 05:01
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Blog
Dec 21, 2024, 05:01
Omolola Salako: A year ago, Pearl Oncology Specialist Hospital became a 24-hour, 10-bed cancer center
Science
Dec 21, 2024, 04:57
Alexandre Chan: Updates on repurposing riluzole as a treatment for cancer-related cognitive impairment